Kevin Caliendo

Q: What is Kevin Caliendo's success rate?

Kevin Caliendo currently has a success rate of 86.07025086615295.

Q: What is the average return of Kevin Caliendo's calls?

Their stock ratings have generated an average return of 28.51209124235773.

UBS | Healthcare

Kevin Caliendo is an analyst from UBS specializing in the Healthcare sector. Ranked #1240 out of 4773 analysts, they have issued 49 stock ratings with a success rate of 86.07% and an average return of 28.51%.

Kevin Caliendo has a well-established track record, with 49 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 86.07% and an average return of 28.51%, underscoring their expertise and ability to identify winning opportunities for investors.

#1240

Out of 4773

Total Ratings

+86.07%

Success Rate

+28.51%

Average Return

Recent Ratings Analysis

LH

Buy

Sep 11, 2026

Target

$380.00

Current

$311.54

Performance

0.00%

Kevin Caliendo rated LH as Buy on Sep 11, 2026, setting a price target of 380. Shares have remained stable near 311.54, leaving the 380 target still in play.

DGX

Hold

Sep 08, 2026

Target

$245.00

Current

$235.02

Performance

-0.20%

On Sep 08, 2026, DGX was given a Neutral rating by Kevin Caliendo, with a target price of 245. Market indecision, reflected in sideways trading near 235.02, supported the cautious call.

HSIC

Hold

Aug 05, 2026

Target

$94.00

Current

$88.36

Performance

-1.37%

HSIC received a Neutral rating from Kevin Caliendo on Aug 05, 2026, aiming for 94. Shares remained flat at 88.36, aligning with the neutral rating.

SOLV

Buy

Jul 28, 2026

Target

$95.00

Current

$87.45

Performance

1.49%

On Jul 28, 2026, Kevin Caliendo published a Buy outlook on SOLV, with a target of 95. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 87.45.

CVS

Buy

Jul 24, 2026

Target

$122.00

Current

$94.66

Performance

-12.14%

Kevin Caliendo on Jul 24, 2026 assigned CVS a Buy rating, with a price target of 122. The call has struggled to gain traction, with shares losing 12.14%.

CAH

Buy

Jul 20, 2026

Target

$274.00

Current

$234.57

Performance

3.91%

On Jul 20, 2026, Kevin Caliendo reaffirmed CAH with a Buy rating, targeting 274. Market indecision has kept the 274 target in a holding pattern.

ACH

Hold

May 12, 2026

Target

$4.50

Current

$1.08

Performance

-66.25%

ACH was rated Neutral by Kevin Caliendo on May 12, 2026, with a price objective of 4.5. Investors who stayed cautious avoided some of the 66.25% decline.

MCK

Buy

May 08, 2026

Target

$1050.00

Current

$881.51

Performance

19.76%

On May 08, 2026, Kevin Caliendo initiated coverage on MCK with a Buy rating and target of 1050. The stock’s climb of 19.76% since the call highlights the foresight in the rating.

COR

Buy

May 07, 2026

Target

$412.00

Current

$321.57

Performance

25.78%

Kevin Caliendo issued a Buy recommendation for COR on May 07, 2026, price target set at 412. Investors following the Buy call captured upside momentum, with shares now at 321.57.

XRAY

Buy

May 07, 2026

Target

$17.00

Current

$10.46

Performance

-4.56%

On May 07, 2026, XRAY was evaluated by Kevin Caliendo, who gave a Buy rating and target of 17. So far, the Buy call awaits clearer momentum, with shares flat at 10.46.

AHCO

Buy

May 06, 2026

Target

$14.00

Current

$6.06

Performance

-46.94%

Kevin Caliendo rated AHCO as Buy on May 06, 2026, setting a price target of 14. The stock has underperformed, dropping 46.94% despite the bullish target of 14.

LFST

Buy

Feb 26, 2026

Target

$12.00

Current

$12.97

Performance

86.35%

On Feb 26, 2026, LFST was given a Buy rating by Kevin Caliendo, with a target price of 12. The stock rallied 86.35% after the rating, narrowing the gap to the target of 12 and validating the bullish stance.

EVH

Buy

Feb 26, 2026

Target

$10.00

Current

$4.19

Performance

26.20%

EVH received a Buy rating from Kevin Caliendo on Feb 26, 2026, aiming for 10. Momentum has favored the Buy call, with shares climbing from 4.19 to 4.19, rewarding those who trusted the recommendation.

MDLN

Buy

Feb 26, 2026

Target

$57.00

Current

$32.53

Performance

-33.46%

On Feb 26, 2026, Kevin Caliendo published a Buy outlook on MDLN, with a target of 57. Market action contradicted the Buy thesis, as shares slipped to 32.53.

ALGN

Hold

Feb 05, 2026

Target

$185.00

Current

$150.82

Performance

-14.12%

Kevin Caliendo on Feb 05, 2026 assigned ALGN a Neutral rating, with a price target of 185. The call successfully avoided chasing as shares lost 14.12%.

NVST

Hold

Feb 03, 2026

Target

$25.00

Current

$25.55

Performance

11.52%

On Feb 03, 2026, Kevin Caliendo reaffirmed NVST with a Neutral rating, targeting 25. Market strength beyond 25.55 went further than the conservative outlook suggested.

ALHC

Hold

Jan 14, 2026

Target

$21.00

Current

$12.61

Performance

-42.02%

ALHC was rated Neutral by Kevin Caliendo on Jan 14, 2026, with a price objective of 21. Investors who stayed cautious avoided some of the 42.02% decline.

GDRX

Hold

Nov 06, 2025

Target

$4.00

Current

$3.39

Performance

7.28%

On Nov 06, 2025, Kevin Caliendo initiated coverage on GDRX with a Neutral rating and target of 4. The Hold stance underestimated the stock’s strength as it gained 7.28%.

OMI

Hold

Nov 03, 2025

Target

$4.00

Current

$2.68

Performance

-22.32%

Kevin Caliendo issued a Neutral recommendation for OMI on Nov 03, 2025, price target set at 4. Market action validated the conservative Hold outlook with shares at 2.68.

UNH

Buy

Oct 29, 2025

Target

$430.00

Current

$379.09

Performance

6.71%

On Oct 29, 2025, UNH was evaluated by Kevin Caliendo, who gave a Buy rating and target of 430. This case illustrates how a timely bullish rating can translate into tangible gains of 6.71%.

MOH

Hold

Oct 24, 2025

Target

$170.00

Current

$204.23

Performance

25.05%

Kevin Caliendo rated MOH as Neutral on Oct 24, 2025, setting a price target of 170. Despite the Hold call, shares climbed 25.05% to 204.23, revealing unexpected momentum.

PINC

Hold

Sep 25, 2025

Target

$28.25

Current

$49.58

Performance

78.41%

On Sep 25, 2025, PINC was given a Neutral rating by Kevin Caliendo, with a target price of 28.25. The stock rallied from 49.58 to 49.58 after the Hold rating, surprising to the upside.

AMWL

Hold

May 08, 2025

Target

$9.00

Current

$13.00

Performance

86.78%

AMWL received a Neutral rating from Kevin Caliendo on May 08, 2025, aiming for 9. Investors saw gains of 86.78% that the cautious stance didn’t fully capture.

CI

Buy

Feb 03, 2025

Target

$390.00

Current

$280.76

Performance

-4.00%

On Feb 03, 2025, Kevin Caliendo published a Buy outlook on CI, with a target of 390. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 280.76.

WBA

Hold

Oct 17, 2024

Target

$10.00

Current

$11.98

Performance

12.38%

Kevin Caliendo on Oct 17, 2024 assigned WBA a Neutral rating, with a price target of 10. Shares outperformed expectations, climbing 12.38% despite the neutral view.

HUM

Hold

Oct 04, 2024

Target

$250.00

Current

$409.85

Performance

70.75%

On Oct 04, 2024, Kevin Caliendo reaffirmed HUM with a Neutral rating, targeting 250. Market strength beyond 409.85 went further than the conservative outlook suggested.

Frequency Asked Questions

Who is Kevin Caliendo?

Kevin Caliendo is an analyst from UBS specializing in the Healthcare sector.

What is Kevin Caliendo's success rate?

Kevin Caliendo currently has a success rate of +86.07%.

How many ratings has Kevin Caliendo issued?

Kevin Caliendo has issued 49 stock ratings so far.

What is the average return of Kevin Caliendo's calls?

Their stock ratings have generated an average return of +28.51%.

What is Kevin Caliendo's ranking?

Kevin Caliendo is ranked #1240 out of 4773 analysts.

What types of ratings does Kevin Caliendo give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kevin Caliendo?

You can follow Kevin Caliendo by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kevin Caliendo?

Their latest rating was a Buy on LH issued on 2026-09-11.